Introduction: In the GI tumors area, key findings from the American Society of Clinical Oncology 2013 annual meeting were long awaited, particularly in colorectal, gastric and pancreatic cancer. Areas covered: The following pages briefly present and comment on a selection of those studies considered most relevant for clinical practice and future research planning. The following trials were then reviewed: The FIRE-3, Triplet + beva (TRIBE), new EPOC, CAIRO-3 and SAKK in colorectal cancer, the TRIO-013/LOGIC and COUGAR-02 in gastric cancer and the metastatic adenocarcinoma of the pancreas (MPACT) and LAP07 in pancreatic cancer. Expert opinion: Although the proportion of clinical questions that these trials were able to answer was almost exactly paralleled by the introduction of new questions to be responded in the next (hopefully) few years, globally they represented a significant improvement in our knowledge about colorectal cancer and pancreatic tumors.

Selected gastrointestinal cancer presentations from the American Society of Clinical Oncology annual meeting 2013 in review: It is not about the destination, it is about the journey

Scartozzi, M;
2014

Abstract

Introduction: In the GI tumors area, key findings from the American Society of Clinical Oncology 2013 annual meeting were long awaited, particularly in colorectal, gastric and pancreatic cancer. Areas covered: The following pages briefly present and comment on a selection of those studies considered most relevant for clinical practice and future research planning. The following trials were then reviewed: The FIRE-3, Triplet + beva (TRIBE), new EPOC, CAIRO-3 and SAKK in colorectal cancer, the TRIO-013/LOGIC and COUGAR-02 in gastric cancer and the metastatic adenocarcinoma of the pancreas (MPACT) and LAP07 in pancreatic cancer. Expert opinion: Although the proportion of clinical questions that these trials were able to answer was almost exactly paralleled by the introduction of new questions to be responded in the next (hopefully) few years, globally they represented a significant improvement in our knowledge about colorectal cancer and pancreatic tumors.
File in questo prodotto:
File Dimensione Formato  
Scartozzi 2014.pdf

Solo gestori archivio

Tipologia: versione editoriale
Dimensione 3.91 MB
Formato Adobe PDF
3.91 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11584/187063
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact